Protocol approach 3: comprehensive repair (thymosin alpha-1 plus BPC-157 plus TB-500) Goal: Immune rebalancing combined with aggressive tissue repair Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week BPC-157: 250 mcg subcutaneously twice daily near affected tissue TB-500 : 2-5 mg subcutaneously twice per week for loading, then weekly for maintenance Rationale: This three-peptide approach targets immune regulation (TA1), mucosal and tissue healing (BPC-157), and cellular migration plus repair (TB-500)
Intestinal glucagon-like peptide-1 effects on food intake: Physiological relevance and emerging mechanisms
Supplement Facts: Serving Size: 1 capsule Servings Per Container: 120 Amount Per Serving: CLA (Conjugated Linoleic Acid): 300 mg L-carnitine tartrate: 200 mg (of which L-carnitine 138 mg) Green tea extract (Camellia sinensis) (4:1): 200 mg (of which polyphenols 100 mg, EGCG 30 mg) *RI - Reference Intake Ingredients: cla (conjugated linoleic acid) powder, bulking agent: microcrystalline cellulose, l-carnitine tartrate, camellia sinensis green tea extract, capsule shell (gelatine, colouring agents: iron oxides and hydroxides), anti-caking agents: silicon dioxide, magnesium salts of fatty acids
Across six randomized, double-blind, placebo-controlled trials, AOD-9604 showed no effect on serum IGF-1, no impairment of glucose tolerance, and no insulin resistance all common problems with full GH therapy (Stier et al., 2013)
:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)
